Answers are grounded in this paper and cite their sources.
We report herein the identification of MK-4409, a potent and selective fatty acid amide hydrolase (FAAH) inhibitor. Starting from a high throughput screening (HTS) hit, medicinal chemistry efforts focused on optimizing of FAAH inhibition in vitro potency, improving the pharmacokinetic (PK) profile, and increasing in vivo efficacy in rodent inflammatory and neuropathic pain assays.
No takes yet. Share an insight, caveat, or question.
Chobanian et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: